Kalvista Capital Lease Obligations from 2010 to 2024
| KALV Stock | USD 10.06 0.03 0.30% |
Capital Lease Obligations | First Reported 2017-07-31 | Previous Quarter 7.3 M | Current Value 6.3 M | Quarterly Volatility 3.5 M |
Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 424 K, Interest Expense of 0.0 or Selling General Administrative of 4.9 M, as well as many indicators such as Price To Sales Ratio of 46.33, Dividend Yield of 0.0 or Days Sales Outstanding of 268. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.
Kalvista | Capital Lease Obligations |
Latest Kalvista Pharmaceuticals' Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of Kalvista Pharmaceuticals over the last few years. Kalvista Pharmaceuticals capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Kalvista Pharmaceuticals asset purchases. For example, Kalvista Pharmaceuticals can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Kalvista Pharmaceuticals control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Kalvista Pharmaceuticals' Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
Kalvista Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 2,449,584 | |
| Geometric Mean | 352,846 | |
| Coefficient Of Variation | 138.16 | |
| Mean Deviation | 2,977,712 | |
| Median | 58,000 | |
| Standard Deviation | 3,384,257 | |
| Sample Variance | 11.5T | |
| Range | 8.2M | |
| R-Value | 0.81 | |
| Mean Square Error | 4.2T | |
| R-Squared | 0.66 | |
| Significance | 0.0002 | |
| Slope | 613,587 | |
| Total Sum of Squares | 160.3T |
Kalvista Capital Lease Obligations History
About Kalvista Pharmaceuticals Financial Statements
Kalvista Pharmaceuticals investors use historical fundamental indicators, such as Kalvista Pharmaceuticals' Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 7.3 M | 4.9 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.